A novel fluorescence-based biosynthetic trafficking method provides pharmacologic evidence that PI4-kinase IIIα is important for protein trafficking from the endoplasmic reticulum...

por Bryant, Kirsten L, Baird, Barbara, Holowka, David
Publicado 2015

KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment

por Zeitouni, Daniel, Pylayeva-Gupta, Yuliya, Der, Channing J., Bryant, Kirsten L.
Publicado 2016

Oncogenic RAS promotes MYC protein stability by upregulating the expression of the inhibitor of apoptosis protein family member Survivin

por Chang, Wen-Hsuan, Liu, Yinzhe, Hammes, Emma A., Bryant, Kirsten L., Cerione, Richard A., Antonyak, Marc A.
Publicado 2022

VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer

por Lee, Ye S., Klomp, Jennifer E., Stalnecker, Clint A., Goodwin, Craig M., Gao, Yanzhe, Droby, Gaith N., Vaziri, Cyrus, Bryant, Kirsten L., Der, Channing J., Cox, Adrienne D.
Publicado 2023

Genome-wide DNA methylation analysis of KRAS mutant cell lines

por Tew, Ben Yi, Durand, Joel K., Bryant, Kirsten L., Hayes, Tikvah K., Peng, Sen, Tran, Nhan L., Gooden, Gerald C., Buckley, David N., Der, Channing J., Baldwin, Albert S., Salhia, Bodour
Publicado 2020

CHK1 protects oncogenic KRAS-expressing cells from DNA damage and is a target for pancreatic cancer treatment

por Klomp, Jennifer E., Lee, Ye S., Goodwin, Craig M., Papke, Björn, Klomp, Jeff A., Waters, Andrew M., Stalnecker, Clint A., DeLiberty, Jonathan M., Drizyte-Miller, Kristina, Yang, Runying, Diehl, J. Nathaniel, Yin, Hongwei H., Pierobon, Mariaelena, Baldelli, Elisa, Ryan, Meagan B., Li, Siqi, Peterson, Jackson, Smith, Amber R., Neal, James T., McCormick, Aaron K., Kuo, Calvin J., Counter, Christopher M., Petricoin, Emanuel F., Cox, Adrienne D., Bryant, Kirsten L., Der, Channing J.
Publicado 2021